Linus Health

Aural Analytics, Inc. is a Scottsdale, Arizona-based company founded in 2015 that focuses on developing applications for monitoring brain health. The company has created a multi-modal brain health analytics platform that utilizes advances in artificial intelligence, neuroscience, and speech analytics to detect changes in neurological health. By leveraging proprietary metrics, Aural Analytics transforms smartphones and tablets into effective brain health monitors, capturing subtle, clinically relevant aspects of a patient's condition through speech samples. This technology enhances traditional functional rating scales used in clinical trials by providing objective, continuous outcomes, thereby allowing for more reliable evaluations of drug efficacy and other interventions. Aural Analytics' platform aims to reveal incremental changes in neurological health, facilitating accurate assessments by medical professionals.

Kinesis Health Technologies is a Dublin-based digital health company founded in 2013 that specializes in assessing physical function and falls risk in older adults. The company has developed a patented platform that monitors mobility impairment by categorizing various mobility parameters such as walking, variability, symmetry, transfers, and turning. By comparing individual mobility scores against population data based on age and gender, Kinesis provides a method for objective assessment of gait, mobility, and frailty. With over a decade of research backing its medical device technologies, Kinesis Health Technologies aims to enhance the prevention and assessment of falls risk, contributing significantly to the health and safety of older adults. The company is supported by a team with extensive experience in business, marketing, and technical fields.

Digital Cognition Technologies, Inc. specializes in the research and development of non-invasive tests designed to detect presymptomatic cognitive impairment. The company’s innovative approach involves analyzing micro-movements in drawing behavior, which provide insights into an individual's memory and thinking processes. These tests are utilized in various contexts, including drug development, where they facilitate the pre-screening of participants and help assess the efficacy of treatments by identifying subtle cognitive changes. Additionally, the tests support researchers in early detection and intervention strategies, enabling timely treatment with both investigational therapies and established medications. Founded in 2015 and based in Waltham, Massachusetts, Digital Cognition Technologies aims to enhance patient care and improve treatment outcomes through early identification of cognitive decline.